which antibacterial agent performs best for the treatment and clearance of chlamydophila felis infection in cats?
Article Quality & Performance Metrics
Readership in this journal
EmergingRanked #9 of 14 articles by views in unep eia training resource manual, case studies from developing countries
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
Clinical bottom line:
Based on the current evidence, oral doxycycline (10mg/kg PO q24h or 5mg/kg PO q12h) for at least 21 days represents the most efficacious treatment, both in terms of clinical improvement and permanent clearance of Chlamydophila felis infection in cats. In chronic infections, or where the duration of disease is unknown, a longer treatment course of 28 days is indicated. There is limited evidence that co-amoxiclav (12.5-22.5mg/kg q12h PO) may be used as an alternative, though a treatment period of at least 30 days is required.
| Reference Key |
mills2017veterinarywhich
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;David Mills |
| Journal | unep eia training resource manual, case studies from developing countries |
| Year | 2017 |
| DOI |
10.18849/ve.v2i1.55
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
ZincirX productsfrom the team behind Journament
-
PatentYazar
Patent drafts for the EPO, USPTO and TürkPatent
From inventor notes to a DOCX draft: description, claims, abstract. The machine drafts, the attorney signs.
See how it works (opens in a new tab) -
Projenator
Have a project idea? Score and plan it with AI
AI scores your idea in five dimensions and builds a phased plan. Your first project is free, no card needed.
Start your first project (opens in a new tab)
Cookies
We use strictly necessary cookies to run the site and keep you signed in. With your permission we would also use Google Analytics to see how the site is used, and Google AdSense to show ads on journal and article pages. Both stay off unless you accept, and you can change your mind at any time. How we use cookies · KVKK notice (Türkiye)
Cookie settings
Comments
No comments yet. Be the first to comment on this article.